IL156218A0 - Method for identifying compounds modulating reverse cholesterol transport - Google Patents

Method for identifying compounds modulating reverse cholesterol transport

Info

Publication number
IL156218A0
IL156218A0 IL15621802A IL15621802A IL156218A0 IL 156218 A0 IL156218 A0 IL 156218A0 IL 15621802 A IL15621802 A IL 15621802A IL 15621802 A IL15621802 A IL 15621802A IL 156218 A0 IL156218 A0 IL 156218A0
Authority
IL
Israel
Prior art keywords
cholesterol transport
reverse cholesterol
methods
identifying compounds
modulating reverse
Prior art date
Application number
IL15621802A
Other languages
English (en)
Original Assignee
Genfit
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genfit filed Critical Genfit
Publication of IL156218A0 publication Critical patent/IL156218A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6897—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids involving reporter genes operably linked to promoters
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biophysics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Vascular Medicine (AREA)
  • Urology & Nephrology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
IL15621802A 2001-02-05 2002-02-04 Method for identifying compounds modulating reverse cholesterol transport IL156218A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0101486A FR2820435B1 (fr) 2001-02-05 2001-02-05 Procedes d'identification de composes modulant le transport inverse du cholesterol
PCT/FR2002/000410 WO2002063038A1 (fr) 2001-02-05 2002-02-04 Procedes d'identification de composes modulant le transport inverse du cholesterol

Publications (1)

Publication Number Publication Date
IL156218A0 true IL156218A0 (en) 2003-12-23

Family

ID=8859595

Family Applications (1)

Application Number Title Priority Date Filing Date
IL15621802A IL156218A0 (en) 2001-02-05 2002-02-04 Method for identifying compounds modulating reverse cholesterol transport

Country Status (14)

Country Link
US (1) US20040115666A1 (xx)
EP (1) EP1358354B1 (xx)
JP (1) JP2004537272A (xx)
KR (1) KR20030074740A (xx)
CN (1) CN1568374A (xx)
AT (1) ATE321887T1 (xx)
AU (1) AU2002234729B2 (xx)
CA (1) CA2437434A1 (xx)
DE (1) DE60210253T2 (xx)
DK (1) DK1358354T3 (xx)
ES (1) ES2260413T3 (xx)
FR (1) FR2820435B1 (xx)
IL (1) IL156218A0 (xx)
WO (1) WO2002063038A1 (xx)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20050159362A1 (en) * 2003-04-22 2005-07-21 Sircar Jagadish C. Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
FR2864105B1 (fr) * 2003-12-23 2008-02-01 Genfit S A Procede pour identifier des composes modulant le transport inverse du cholesterol
MXJL06000070A (es) * 2004-06-09 2007-04-10 Avanir Pharmaceuticals Pequenas moleculas para el tratamiento de hipercolesterolemia y enfermedades relacionadas.
CA2568543A1 (en) * 2004-06-09 2005-12-29 Avanir Pharmaceuticals Mediators of reverse cholesterol transport for the treatment of hypercholesterolemia
PE20050986A1 (es) * 2004-06-09 2006-02-03 Avanir Pharmaceuticals Derivados heterociclicos mediadores del transporte inverso de colesterol
KR100784859B1 (ko) * 2005-01-14 2007-12-14 한국과학기술연구원 형광편광도를 이용한 파네소이드 ｘ 수용체-리간드복합체의 상호작용 분석방법 및 결합 저해물질 검색방법
WO2007055873A2 (en) * 2005-11-04 2007-05-18 Avanir Pharmaceuticals Process for the manufacture of peptide facilitators of reverse cholesterol transport

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721096A (en) * 1991-01-24 1998-02-24 Children's Medical Center Corporation Methods of screening for compounds with ability to alter apolipoprotein AI gene expression
DE19709125A1 (de) * 1997-03-06 1998-09-10 Bayer Ag Substituierte Chinoline
JP2000109455A (ja) * 1998-08-06 2000-04-18 Shionogi & Co Ltd アポリポタンパク質ａｉ遺伝子発現亢進作用を有する化合物
WO2000040965A1 (en) * 1999-01-07 2000-07-13 Tularik, Inc. Fxr receptor-mediated modulation of cholesterol metabolism
DE60029029T2 (de) * 1999-03-26 2007-06-14 City Of Hope, Duarte Screenen nach FXR-Rezeptormodulatoren
US20020132223A1 (en) * 1999-03-26 2002-09-19 City Of Hope Methods for modulating activity of the FXR nuclear receptor

Also Published As

Publication number Publication date
CN1568374A (zh) 2005-01-19
CA2437434A1 (fr) 2002-08-15
JP2004537272A (ja) 2004-12-16
FR2820435B1 (fr) 2004-02-27
WO2002063038A1 (fr) 2002-08-15
KR20030074740A (ko) 2003-09-19
DE60210253D1 (de) 2006-05-18
DK1358354T3 (da) 2006-07-31
EP1358354A1 (fr) 2003-11-05
ES2260413T3 (es) 2006-11-01
ATE321887T1 (de) 2006-04-15
EP1358354B1 (fr) 2006-03-29
AU2002234729B2 (en) 2007-05-31
US20040115666A1 (en) 2004-06-17
FR2820435A1 (fr) 2002-08-09
DE60210253T2 (de) 2007-03-15

Similar Documents

Publication Publication Date Title
NO20025402D0 (no) Modifiserte ES-celler og ES-spesifikt gen
WO2001057251A3 (en) Methods and apparatus for predicting, confirming, and displaying functional information derived from genomic sequence
ATE421991T1 (de) Stammzellen und verfahren zu deren trennung
FI20051339A (fi) Pikasanomavälitykseen perustuva informaatiopalautemenetelmä ja järjestelmä sitä varten
WO2005012574A3 (en) Biological bar-code
EP0892048A3 (en) XAF genes and polypeptides and their use for modulating apoptosis
IL156218A0 (en) Method for identifying compounds modulating reverse cholesterol transport
WO2002040668A3 (de) Proteine und den proteinen zugrundeliegende dna-sequenzen mit funktion bei entzündungsereignissen
WO2004050842A3 (en) Atm kinase compositions and methods
WO2001096604A3 (en) Assay for genetic polymorphisms using scattered light detectable labels
DK0942999T3 (da) Genfælde-konstrukt til identificering og isolering af gener
WO2004101764A3 (en) Methods of modulating metastasis and skeletal related events resulting from metastases
WO2002079391A3 (en) Methods and apparatus for discovering, identifying and comparing biological activity mechanisms
WO2001049721A3 (en) Bacterial genes and proteins that are essential for cell viability and their uses
WO2000009693A3 (en) Identification of the gene causing the mouse scurfy phenotype and its human ortholog
WO2001009384A3 (en) Serial analysis of genetic alterations
WO2003068940A3 (en) Complexes and methods of using same
WO1998049333A3 (en) Eukaryotic gene expression cassette and uses thereof
WO2000040757A3 (en) Method of identifying nucleic acids
DK1082415T3 (da) Anvendelige fremgangsmåder til modulation af angioge-nese ved anvendelse af tyrosin kinase SRC
WO1995017522A3 (en) Identification of simple tandem repeats
EP1268842A4 (en) IMPROVED N HYBRID REVERSE SCREENING METHOD
WO2003066867A3 (en) Genetically engineered phic31-integrase genes
DK1127943T3 (da) Midler og fremgangsmåder til ekspression af homologe og heterologe proteiner i stammer af Rhodococcus
WO2003029409A3 (en) Methods for generating, selecting, and identifying compounds which bind a target molecule